US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 1.740
- +0.120+7.41%
Close Nov 27 16:00 ET
- 1.680
- -0.060-3.45%
Post 19:46 ET
9.92MMarket Cap-504P/E (TTM)
1.820High1.620Low151.00KVolume1.620Open1.620Pre Close261.62KTurnover3.39%Turnover RatioLossP/E (Static)5.70MShares11.89052wk High-1.64P/B7.75MFloat Cap1.05052wk Low--Dividend TTM4.45MShs Float787.500Historical High--Div YieldTTM12.35%Amplitude1.050Historical Low1.732Avg Price1Lot Size
Brainstorm Cell Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48.53%-3.3M | 75.17%-1.68M | 23.16%-3.06M | -5.89%-20.46M | -13.70%-5.29M | -32.14%-6.41M | -10.50%-6.78M | -8.08%-3.99M | 26.44%-19.32M | 15.61%-4.65M |
| Net income from continuing operations | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M | 0.74%-24.28M | 18.93%-5.02M |
| Operating gains losses | 91.72%-394K | ---411K | --940K | ---4.53M | --236K | ---4.76M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -9.23%59K | -4.48%64K | -4.48%64K | -7.02%265K | -5.71%66K | -7.14%65K | -5.63%67K | -9.46%67K | 9.62%285K | 0.00%70K |
| Change In working capital | 58.07%-434K | 140.38%1.01M | -183.43%-836K | -116.59%-496K | 153.25%41K | -167.08%-1.04M | -680.97%-2.5M | -8.33%1M | 187.07%2.99M | 63.33%-77K |
| -Change in receivables | -56.81%149K | -44.12%133K | 120.90%121K | -144.52%-475K | -3,321.43%-479K | -24.51%345K | -20.93%238K | -279.26%-579K | 218.51%1.07M | 98.46%-14K |
| -Change in payables and accrued expense | 53.63%-613K | 132.72%882K | -157.47%-954K | -106.99%-176K | 258.26%182K | -218.04%-1.32M | -531.36%-2.7M | 87.15%1.66M | 167.62%2.52M | -115.44%-115K |
| -Change in other current liabilities | 151.72%30K | 91.30%-4K | 96.20%-3K | 126.09%155K | 550.00%338K | -70.59%-58K | 90.71%-46K | 32.48%-79K | -1,163.83%-594K | --52K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.53%-3.3M | 75.17%-1.68M | 23.16%-3.06M | -5.89%-20.46M | 29.32%-3.29M | -32.14%-6.41M | -10.50%-6.78M | -8.08%-3.99M | 26.44%-19.32M | 15.61%-4.65M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 119.74%2.19M | -81.12%196K | -9.09%-12K | 133.33%4K | 11,894.12%2.01M | 208.98%998K | 180.03%1.04M |
| Net PPE purchase and sale | ---- | ---- | ---- | 37.93%-18K | --0 | -1,700.00%-18K | ---- | ---- | 91.21%-29K | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | 115.29%2.21M | -81.12%196K | 160.00%6K | -42.86%4K | 25,162.50%2.01M | 57.27%1.03M | 182.25%1.04M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 119.74%2.19M | -81.12%196K | -9.09%-12K | 133.33%4K | 11,894.12%2.01M | 208.98%998K | 180.03%1.04M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -17.53%4.37M | -21.39%2.54M | 7,873.95%18.98M | 1,308.40%3.35M | 7.1M | 5.3M | 3.23M | -96.58%238K | 800.00%238K |
| Net common stock issuance | --0 | -17.53%4.37M | -21.39%2.54M | 7,873.95%18.98M | 1,308.40%3.35M | --7.1M | --5.3M | --3.23M | -96.58%238K | 800.00%238K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -17.53%4.37M | -21.39%2.54M | 7,873.95%18.98M | 1,308.40%3.35M | --7.1M | --5.3M | --3.23M | -96.58%238K | 800.00%238K |
| Net cash flow | ||||||||||
| Beginning cash position | 568.13%3.65M | -52.45%961K | 92.36%1.49M | -95.91%772K | -70.51%1.22M | -93.94%546K | -86.66%2.02M | -95.91%772K | -50.15%18.86M | -83.87%4.14M |
| Current changes in cash | -588.02%-3.3M | 282.17%2.69M | -141.95%-524K | 103.94%713K | 107.80%263K | 113.91%676K | 76.00%-1.48M | 133.71%1.25M | 4.69%-18.08M | 50.69%-3.37M |
| End cash Position | -71.44%349K | 568.13%3.65M | -52.45%961K | 92.36%1.49M | 92.36%1.49M | -70.51%1.22M | -93.94%546K | -86.66%2.02M | -95.91%772K | -95.91%772K |
| Free cash flow | 48.67%-3.3M | 75.17%-1.68M | 23.16%-3.06M | -5.82%-20.48M | 29.32%-3.29M | -32.49%-6.43M | -10.16%-6.78M | -7.82%-3.99M | 27.25%-19.35M | 16.15%-4.65M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data